Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

eIF5A1 Inhibitors

eIF5A1 Inhibitors are a specialized class of chemical compounds that target and inhibit the activity of eukaryotic initiation factor 5A1 (eIF5A1), a highly conserved protein involved in the regulation of translation. eIF5A1 is unique because it is the only known protein to undergo post-translational modification by hypusination, a process that is crucial for its function in promoting the synthesis of specific proteins, particularly those involved in cell proliferation, differentiation, and stress responses. By inhibiting eIF5A1, researchers can study the detailed mechanisms of translation elongation and the role of hypusinated eIF5A1 in various cellular processes, including the synthesis of proteins that are otherwise challenging to produce or regulate within the cell.

The inhibition of eIF5A1 is particularly valuable for exploring its involvement in the regulation of proteins with proline-rich sequences, which are known to be critical for the control of cell cycle progression and apoptosis. eIF5A1 Inhibitors provide a powerful tool for dissecting the molecular pathways that rely on these specific proteins, allowing scientists to gain insights into how cells regulate essential functions like growth, division, and response to environmental stressors. Furthermore, these inhibitors offer a way to study the broader impact of translation control on cellular homeostasis and the maintenance of protein quality. By modulating eIF5A1 activity, researchers can explore how the balance of protein synthesis and degradation is maintained in the cell and how disruptions to this balance can lead to various cellular outcomes. Overall, eIF5A1 Inhibitors serve as a critical resource for advancing our understanding of the complex network of interactions that govern translation and protein synthesis in eukaryotic cells.

SEE ALSO...

Items 1 to 10 of 18 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$33.00
$102.00
87
(2)

Salubrinal inhibits eIF2α dephosphorylation, leading to prolonged phosphorylation, which reduces translation initiation.

Guanabenz HCl

23113-43-1sc-507500
100 mg
$241.00
(0)

Guanabenz reduces eIF2α phosphorylation by activating the eIF2α phosphatase, PP1, allowing translation to proceed normally.

GSK 2606414

1337531-36-8sc-490182
sc-490182A
5 mg
25 mg
$160.00
$561.00
(0)

GSK2606414 inhibits the activity of PERK, a kinase that phosphorylates eIF2α, reducing eIF2α phosphorylation levels.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Cisplatin indirectly affects eIF2α by causing DNA damage, triggering the integrated stress response and eIF2α phosphorylation.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin induces ER stress, activating PERK and leading to eIF2α phosphorylation, thereby inhibiting protein synthesis.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide causes DNA damage, which could lead to a cellular stress response, potentially diverting cellular resources from RNAi pathways and thus down-regulating eIF2C2.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

By acting as a pyrimidine analog, 5-Fluorouracil might disrupt nucleotide metabolism. This disruption could indirectly affect RNAi components by hampering RNA synthesis, leading to decreased eIF2C2 levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib inhibits the proteasome, affecting protein turnover. This can disrupt the balance of cellular proteins, potentially decreasing the stability or synthesis of eIF2C2.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D hinders RNA synthesis by intercalating DNA. This can lead to a general down-regulation of RNA-derived processes, which might include a decrease in eIF2C2 levels.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

By inhibiting protein synthesis, Cycloheximide might halt the production of new eIF2C2 molecules, leading to a net decrease in eIF2C2 as existing proteins degrade.